These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 17376822

  • 1. Development of new-generation HU-PBMC-NOD/SCID mice to study human islet alloreactivity.
    King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson M, Wasserfall C, Herold K, Mordes JP, Rossini AA, Greiner DL.
    Ann N Y Acad Sci; 2007 Apr; 1103():90-3. PubMed ID: 17376822
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research.
    Shultz LD, Pearson T, King M, Giassi L, Carney L, Gott B, Lyons B, Rossini AA, Greiner DL.
    Ann N Y Acad Sci; 2007 Apr; 1103():77-89. PubMed ID: 17332083
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
    Banuelos SJ, Shultz LD, Greiner DL, Burzenski LM, Gott B, Lyons BL, Rossini AA, Appel MC.
    Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development.
    Camacho RE, Wnek R, Fischer P, Shah K, Zaller DM, Woods A, La Monica N, Aurisicchio L, Fitzgerald-Bocarsly P, Koo GC.
    Exp Hematol; 2007 Aug; 35(8):1219-30. PubMed ID: 17662890
    [Abstract] [Full Text] [Related]

  • 7. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
    Matsui-Inohara H, Uematsu H, Narita T, Satoh K, Yonezawa H, Kuroda K, Ito T, Yoneda S, Kawarai T, Sugiya H, Watanabe H, Senpuku H.
    Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
    [Abstract] [Full Text] [Related]

  • 8. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
    Ito A, Ishida T, Utsunomiya A, Sato F, Mori F, Yano H, Inagaki A, Suzuki S, Takino H, Ri M, Kusumoto S, Komatsu H, Iida S, Inagaki H, Ueda R.
    J Immunol; 2009 Oct 01; 183(7):4782-91. PubMed ID: 19748990
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice.
    Martin AP, Grisotto MG, Canasto-Chibuque C, Kunkel SL, Bromberg JS, Furtado GC, Lira SA.
    Diabetes; 2008 Feb 01; 57(2):387-94. PubMed ID: 18003753
    [Abstract] [Full Text] [Related]

  • 13. Immune cells, pancreas development, regeneration and type 1 diabetes.
    Homo-Delarche F, Drexhage HA.
    Trends Immunol; 2004 May 01; 25(5):222-9. PubMed ID: 15099561
    [No Abstract] [Full Text] [Related]

  • 14. Generation of transgenic mice on an NOD/SCID background using the conventional microinjection technique.
    Kumagai K, Kubota N, Saito TI, Sasako T, Takizawa R, Sudo K, Kurokawa M, Kadowaki T.
    Biol Reprod; 2011 Apr 01; 84(4):682-8. PubMed ID: 21148106
    [Abstract] [Full Text] [Related]

  • 15. Humanized NOD/SCID/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis.
    Watanabe S, Ohta S, Yajima M, Terashima K, Ito M, Mugishima H, Fujiwara S, Shimizu K, Honda M, Shimizu N, Yamamoto N.
    J Virol; 2007 Dec 01; 81(23):13259-64. PubMed ID: 17881441
    [Abstract] [Full Text] [Related]

  • 16. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
    Pino S, Brehm MA, Covassin-Barberis L, King M, Gott B, Chase TH, Wagner J, Burzenski L, Foreman O, Greiner DL, Shultz LD.
    Methods Mol Biol; 2010 Dec 01; 602():105-17. PubMed ID: 20012395
    [Abstract] [Full Text] [Related]

  • 17. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
    Ito R, Katano I, Kawai K, Hirata H, Ogura T, Kamisako T, Eto T, Ito M.
    Transplantation; 2009 Jun 15; 87(11):1654-8. PubMed ID: 19502956
    [Abstract] [Full Text] [Related]

  • 18. In situ reconstruction of humoral immune response against sperm: comparison of SCID and NOD/SCID mouse models.
    Grygielska B, Kamieniczna M, Wiland E, Kurpisz M.
    Am J Reprod Immunol; 2009 Feb 15; 61(2):147-57. PubMed ID: 19143678
    [Abstract] [Full Text] [Related]

  • 19. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
    Watanabe Y, Takahashi T, Okajima A, Shiokawa M, Ishii N, Katano I, Ito R, Ito M, Minegishi M, Minegishi N, Tsuchiya S, Sugamura K.
    Int Immunol; 2009 Jul 15; 21(7):843-58. PubMed ID: 19515798
    [Abstract] [Full Text] [Related]

  • 20. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.
    Verda L, Kim DA, Ikehara S, Statkute L, Bronesky D, Petrenko Y, Oyama Y, He X, Link C, Vahanian NN, Burt RK.
    Stem Cells; 2008 Feb 15; 26(2):381-6. PubMed ID: 17975228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.